科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/09/05 | 3,795 | 3,815 | 3,770 | 3,810 | -10 | -0.3% | 57,300 |
| 2022/09/02 | 3,810 | 3,830 | 3,780 | 3,820 | ±0 | ±0% | 78,300 |
| 2022/09/01 | 3,850 | 3,865 | 3,800 | 3,820 | -50 | -1.3% | 71,300 |
| 2022/08/31 | 3,825 | 3,880 | 3,825 | 3,870 | ±0 | ±0% | 48,300 |
| 2022/08/30 | 3,850 | 3,885 | 3,840 | 3,870 | +25 | +0.7% | 33,600 |
| 2022/08/29 | 3,795 | 3,855 | 3,790 | 3,845 | -20 | -0.5% | 57,400 |
| 2022/08/26 | 3,915 | 3,915 | 3,855 | 3,865 | -35 | -0.9% | 46,500 |
| 2022/08/25 | 3,900 | 3,920 | 3,880 | 3,900 | ±0 | ±0% | 53,200 |
| 2022/08/24 | 3,880 | 3,905 | 3,860 | 3,900 | +20 | +0.5% | 43,400 |
| 2022/08/23 | 3,865 | 3,895 | 3,850 | 3,880 | -25 | -0.6% | 45,700 |
| 2022/08/22 | 3,870 | 3,920 | 3,865 | 3,905 | +30 | +0.8% | 62,800 |
| 2022/08/19 | 3,890 | 3,915 | 3,875 | 3,875 | ±0 | ±0% | 68,900 |
| 2022/08/18 | 3,885 | 3,885 | 3,860 | 3,875 | -25 | -0.6% | 34,700 |
| 2022/08/17 | 3,875 | 3,905 | 3,860 | 3,900 | +35 | +0.9% | 52,100 |
| 2022/08/16 | 3,865 | 3,870 | 3,820 | 3,865 | +5 | +0.1% | 38,800 |
| 2022/08/15 | 3,880 | 3,885 | 3,840 | 3,860 | -20 | -0.5% | 50,400 |
| 2022/08/12 | 3,845 | 3,895 | 3,835 | 3,880 | +65 | +1.7% | 84,700 |
| 2022/08/10 | 3,740 | 3,820 | 3,740 | 3,815 | +50 | +1.3% | 51,100 |
| 2022/08/09 | 3,785 | 3,795 | 3,740 | 3,765 | -15 | -0.4% | 42,100 |
| 2022/08/08 | 3,810 | 3,840 | 3,770 | 3,780 | -35 | -0.9% | 49,500 |
| 2022/08/05 | 3,740 | 3,820 | 3,740 | 3,815 | +75 | +2% | 93,900 |
| 2022/08/04 | 3,780 | 3,785 | 3,715 | 3,740 | +30 | +0.8% | 78,400 |
| 2022/08/03 | 3,775 | 3,780 | 3,680 | 3,710 | -65 | -1.7% | 195,900 |
| 2022/08/02 | 3,870 | 3,870 | 3,760 | 3,775 | -120 | -3.1% | 93,500 |
| 2022/08/01 | 3,875 | 3,895 | 3,850 | 3,895 | +15 | +0.4% | 66,400 |
| 2022/07/29 | 3,965 | 3,965 | 3,860 | 3,880 | -95 | -2.4% | 88,000 |
| 2022/07/28 | 3,980 | 3,985 | 3,930 | 3,975 | -10 | -0.3% | 51,900 |
| 2022/07/27 | 4,020 | 4,040 | 3,970 | 3,985 | -35 | -0.9% | 50,800 |
| 2022/07/26 | 4,020 | 4,055 | 3,995 | 4,020 | ±0 | ±0% | 60,200 |
| 2022/07/25 | 4,050 | 4,060 | 4,005 | 4,020 | -25 | -0.6% | 49,200 |
| 2022/07/22 | 4,050 | 4,075 | 4,035 | 4,045 | +10 | +0.2% | 74,200 |
| 2022/07/21 | 3,935 | 4,040 | 3,930 | 4,035 | +30 | +0.7% | 81,500 |
| 2022/07/20 | 4,020 | 4,020 | 3,965 | 4,005 | +75 | +1.9% | 120,000 |
| 2022/07/19 | 3,945 | 3,945 | 3,880 | 3,930 | -15 | -0.4% | 60,800 |
| 2022/07/15 | 3,995 | 4,010 | 3,940 | 3,945 | -35 | -0.9% | 62,400 |
| 2022/07/14 | 3,950 | 3,990 | 3,950 | 3,980 | +30 | +0.8% | 49,700 |
| 2022/07/13 | 3,950 | 3,985 | 3,950 | 3,950 | -5 | -0.1% | 40,200 |
| 2022/07/12 | 3,985 | 3,990 | 3,935 | 3,955 | -40 | -1% | 67,800 |
| 2022/07/11 | 3,930 | 3,995 | 3,930 | 3,995 | +100 | +2.6% | 92,500 |
| 2022/07/08 | 3,900 | 3,955 | 3,850 | 3,895 | -10 | -0.3% | 121,800 |
| 2022/07/07 | 3,940 | 3,940 | 3,870 | 3,905 | ±0 | ±0% | 77,600 |
| 2022/07/06 | 3,855 | 3,920 | 3,855 | 3,905 | +40 | +1% | 79,100 |
| 2022/07/05 | 3,880 | 3,880 | 3,835 | 3,865 | ±0 | ±0% | 72,500 |
| 2022/07/04 | 3,845 | 3,880 | 3,845 | 3,865 | +55 | +1.4% | 60,800 |
| 2022/07/01 | 3,830 | 3,880 | 3,805 | 3,810 | -5 | -0.1% | 78,200 |
| 2022/06/30 | 3,845 | 3,880 | 3,805 | 3,815 | +15 | +0.4% | 133,800 |
| 2022/06/29 | 3,750 | 3,805 | 3,750 | 3,800 | +45 | +1.2% | 129,600 |
| 2022/06/28 | 3,730 | 3,780 | 3,710 | 3,755 | ±0 | ±0% | 93,900 |
| 2022/06/27 | 3,780 | 3,780 | 3,730 | 3,755 | -10 | -0.3% | 42,900 |
| 2022/06/24 | 3,765 | 3,770 | 3,740 | 3,765 | +10 | +0.3% | 41,000 |
651～
700
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サワイＧＨＤ | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 379,500円 | +14.5% | -2.3% | 2.37% | 13.88倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 229,900円 | - | - | 0.00% | - | 106.48倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
